Index Performance
Overview
Description
The healthcare services industry in the U.S. is a robust and dynamic sector, underpinned by the increasing demand for medical services due to demographic shifts such as an aging population, advancements in medical treatments, and a heightened focus on health and wellness precipitated by public health challenges like the COVID-19 pandemic. The growth is also driven by innovation in healthcare technologies and services, such as telemedicine, as well as regulatory changes and governmental policies which influence reimbursement rates and coverage. With the integration of IT in healthcare, the emphasis on cost reduction and outcome improvement, alongside rising insurance coverage, the sector is poised for upward growth. However, it is also susceptible to policy changes, which adds a level of uncertainty to its long-term prospects. Investing within the healthcare services industry can be varied with several subcategories of interest under the given criteria. [[Integrated Healthcare Services]] are businesses that offer a spectrum of services from primary care to specialized surgeries, optimizing coordinated care and potentially offering significant efficiency. [[Healthcare Technology and Data Analytics]] signifies companies that focus on the integration of IT to improve patient care, enhance data management, and support remote healthcare services, which is particularly relevant in an era of increased telemedicine utilization. [[Managed Healthcare Providers]] describes organizations that arrange for the delivery of healthcare services to patients, attempting to reduce healthcare costs while improving quality of care. [[Pharmaceutical Services and Distribution]] encompasses companies involved in the wholesale distribution of pharmaceuticals and health products as well as the provision of value-added services to the healthcare sector. [[Medical Supplies and Devices]] covers firms specializing in the manufacture and supply of medical equipment, which have found increasing demands following global health crises, technological improvements, and the trend of surgeries moving towards outpatient settings. Each of these subcategories have distinct growth drivers and risks, and demand a thorough analysis of financial health, market position, regulatory pressures, and technological adaptability to determine the strongest investment candidates. This index was generated with help from Thematic Assist.
- TickerHCAP
- Inception Date12/03/2023
- WeightingEqual
- # of holdings66
What's inside?
Holdings
All holdings as of December 12, 2025
| EXACT Sciences Corp. (EXAS) | 2.68% | $19.26B | 20.05% | 68.64% | 3.86 |
| Teva Pharmaceutical Industries Ltd. (TEVA) | 2.28% | $34.36B | 3.17% | 51.33% | 2.28 |
| Eli Lilly & Co. (LLY) | 1.92% | $971.39B | 53.87% | 82.91% | 12.09 |
| Cardinal Health, Inc. (CAH) | 1.87% | $47.09B | 22.44% | 3.49% | 0.18 |
| Align Technology, Inc. (ALGN) | 1.77% | $11.87B | 1.82% | 67.00% | 2.06 |
| Cognizant Technology Solutions Corp. (CTSH) | 1.77% | $40.51B | 7.36% | 31.58% | 1.51 |
| Regeneron Pharmaceuticals, Inc. (REGN) | 1.76% | $77.91B | 0.90% | 82.47% | 3.83 |
| Charles River Laboratories International, Inc. (CRL) | 1.75% | $9.50B | -0.49% | 32.32% | 2.44 |
| Merck & Co., Inc. (MRK) | 1.75% | $248.95B | 2.80% | 75.59% | 3.64 |
| Intuitive Surgical, Inc. (ISRG) | 1.74% | $192.25B | 22.91% | 66.36% | 16.33 |
| Biogen, Inc. (BIIB) | 1.72% | $25.54B | 3.33% | 64.29% | 2.40 |
| Johnson & Johnson (JNJ) | 1.70% | $509.76B | 6.77% | 69.72% | 5.03 |
| HCA Healthcare, Inc. (HCA) | 1.70% | $110.62B | 9.57% | 15.47% | 2.00 |
| Cencora, Inc. (COR) | 1.68% | $67.12B | 9.31% | 3.16% | 0.21 |
| Thermo Fisher Scientific, Inc. (TMO) | 1.68% | $215.01B | 4.94% | 41.29% | 4.75 |
| IQVIA Holdings, Inc. (IQV) | 1.67% | $37.85B | 5.29% | 26.49% | 2.89 |
| United Therapeutics Corp. (UTHR) | 1.66% | $21.27B | 6.76% | 87.38% | 5.45 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 1.66% | $114.69B | 12.27% | 86.69% | 8.22 |
| Bristol Myers Squibb Co. (BMY) | 1.66% | $106.69B | 2.77% | 66.00% | 2.63 |
| Viatris, Inc. (VTRS) | 1.65% | $13.42B | 0.13% | 36.87% | 1.79 |
| Ventas, Inc. (VTR) | 1.64% | $37.47B | 20.44% | 19.49% | 8.18 |
| McKesson Corp. (MCK) | 1.64% | $100.44B | 10.14% | 3.19% | 0.27 |
| Hologic, Inc. (HOLX) | 1.59% | $16.72B | 1.74% | 55.77% | 3.83 |
| Quanta Services, Inc. (PWR) | 1.59% | $65.33B | 17.53% | 14.19% | 2.51 |
| Amgen, Inc. (AMGN) | 1.58% | $171.10B | 13.32% | 67.85% | 5.52 |
| GE Healthcare Technologies, Inc. (GEHC) | 1.58% | $38.25B | 5.76% | 38.73% | 2.04 |
| Edwards Lifesciences Corp. (EW) | 1.57% | $48.21B | 14.67% | 78.29% | 7.21 |
| Agilent Technologies, Inc. (A) | 1.56% | $39.54B | 6.73% | 52.43% | 6.23 |
| Incyte Corp. (INCY) | 1.55% | $18.73B | 20.05% | 91.50% | 2.95 |
| Pfizer Inc. (PFE) | 1.54% | $146.98B | -5.92% | 67.15% | 2.91 |
| IDEXX Laboratories, Inc. (IDXX) | 1.51% | $56.23B | 13.29% | 62.01% | 12.59 |
| ICON plc (ICLR) | 1.51% | $14.25B | 0.63% | 22.32% | 2.07 |
| CVS Health Corp. (CVS) | 1.50% | $100.82B | 7.83% | 13.43% | 0.42 |
| Gilead Sciences, Inc. (GILD) | 1.49% | $149.38B | 3.36% | 79.84% | 5.33 |
| Medtronic Plc (MDT) | 1.49% | $128.03B | 6.64% | 60.45% | 4.07 |
| Neurocrine Biosciences, Inc. (NBIX) | 1.48% | $15.24B | 27.78% | 98.24% | 5.13 |
| West Pharmaceutical Services, Inc. (WST) | 1.48% | $19.25B | 7.69% | 36.49% | 6.20 |
| Teleflex, Inc. (TFX) | 1.45% | $5.61B | 19.45% | 49.53% | 2.42 |
| Leidos Holdings, Inc. (LDOS) | 1.43% | $24.26B | 6.66% | 18.37% | 1.71 |
| STERIS Plc (Ireland) (STE) | 1.43% | $24.71B | 9.89% | 44.16% | 4.59 |
| AbbVie, Inc. (ABBV) | 1.42% | $394.69B | 9.10% | 66.12% | 7.94 |
| Quest Diagnostics, Inc. (DGX) | 1.40% | $20.31B | 13.18% | 32.35% | 2.54 |
| Ecolab, Inc. (ECL) | 1.40% | $74.66B | 4.16% | 44.79% | 5.35 |
| DexCom, Inc. (DXCM) | 1.40% | $26.12B | 21.64% | 61.80% | 5.91 |
| Jabil, Inc. (JBL) | 1.39% | $23.76B | 3.18% | 8.84% | 0.82 |
| SS&C Technologies Holdings, Inc. (SSNC) | 1.38% | $21.23B | 6.97% | 47.69% | 4.20 |
| BioMarin Pharmaceutical, Inc. (BMRN) | 1.38% | $10.24B | 5.98% | 81.58% | 3.09 |
| Okta, Inc. (OKTA) | 1.36% | $15.98B | 11.58% | 77.09% | 5.03 |
| Xylem, Inc. (XYL) | 1.35% | $33.38B | 7.70% | 38.76% | 4.18 |
| Laboratory Corporation of America Holdings (LH) | 1.34% | $21.93B | 8.58% | 26.82% | 2.18 |
| Boston Scientific Corp. (BSX) | 1.33% | $137.24B | 20.34% | 65.31% | 8.11 |
| Tencent Holdings Ltd. (TCEHY) | 1.33% | $717.05B | 15.52% | 54.31% | 7.88 |
| Stryker Corp. (SYK) | 1.32% | $135.41B | 10.25% | 61.86% | 6.43 |
| Abbott Laboratories (ABT) | 1.30% | $218.16B | 6.90% | 52.05% | 5.47 |
| ResMed, Inc. (RMD) | 1.30% | $36.82B | 9.07% | 60.56% | 7.54 |
| Zimmer Biomet Holdings, Inc. (ZBH) | 1.29% | $18.15B | 9.71% | 62.70% | 3.30 |
| Sony Group Corp. (SONY) | 1.28% | $163.94B | 8.24% | 32.42% | 2.06 |
| Insulet Corp. (PODD) | 1.26% | $20.80B | 29.86% | 72.70% | 8.76 |
| Avantor, Inc. (AVTR) | 1.26% | $7.62B | -5.28% | 32.42% | 1.84 |
| Roper Technologies, Inc. (ROP) | 1.24% | $47.99B | 14.33% | 69.54% | 8.18 |
| Carrier Global Corp. (CARR) | 1.24% | $44.59B | -6.77% | 26.17% | 2.83 |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 1.23% | $52.52B | 149.35% | 83.98% | 19.53 |
| Baxter International, Inc. (BAX) | 1.18% | $9.84B | 5.04% | 33.09% | 1.78 |
| Veeva Systems, Inc. (VEEV) | 1.13% | $36.70B | 16.02% | 75.09% | 13.85 |
| Paycom Software, Inc. (PAYC) | 1.08% | $9.37B | 9.15% | 74.15% | 5.72 |
| Alexandria Real Estate Equities, Inc. (ARE) | 0.77% | $8.06B | -5.01% | 22.94% | 10.51 |